Id |
Subject |
Object |
Predicate |
Lexical cue |
T207 |
6-16 |
VBD |
denotes |
correlated |
T208 |
17-21 |
IN |
denotes |
with |
T209 |
22-30 |
NN |
denotes |
severity |
T210 |
30-31 |
-COMMA- |
denotes |
, |
T211 |
32-43 |
NN |
denotes |
criticality |
T212 |
43-44 |
-COMMA- |
denotes |
, |
T213 |
45-50 |
JJ |
denotes |
viral |
T214 |
51-55 |
NN |
denotes |
load |
T215 |
55-56 |
-COMMA- |
denotes |
, |
T216 |
57-60 |
CC |
denotes |
and |
T217 |
61-70 |
NN |
denotes |
prognosis |
T218 |
71-73 |
IN |
denotes |
of |
T219 |
74-82 |
NNS |
denotes |
patients |
T220 |
83-87 |
IN |
denotes |
with |
T221 |
88-96 |
NN |
denotes |
COVID-19 |
T222 |
98-109 |
NNP |
denotes |
Tocilizumab |
T223 |
109-110 |
-COMMA- |
denotes |
, |
T224 |
111-112 |
DT |
denotes |
a |
T225 |
113-123 |
JJ |
denotes |
monoclonal |
T226 |
124-132 |
NN |
denotes |
antibody |
T227 |
133-140 |
IN |
denotes |
against |
T228 |
141-144 |
NN |
denotes |
IL6 |
T229 |
144-145 |
-COMMA- |
denotes |
, |
R199 |
T207 |
T208 |
arg1Of |
correlated,with |
R200 |
T209 |
T208 |
arg2Of |
severity,with |
R201 |
T209 |
T210 |
arg1Of |
severity,"," |
R202 |
T211 |
T210 |
arg2Of |
criticality,"," |
R204 |
T214 |
T212 |
arg2Of |
load,"," |
R205 |
T214 |
T213 |
arg1Of |
load,viral |
R206 |
T216 |
T215 |
arg1Of |
and,"," |
R207 |
T212 |
T216 |
arg1Of |
",",and |
R208 |
T217 |
T216 |
arg2Of |
prognosis,and |
R209 |
T217 |
T218 |
arg1Of |
prognosis,of |
R210 |
T219 |
T218 |
arg2Of |
patients,of |
R211 |
T219 |
T220 |
arg1Of |
patients,with |
R212 |
T221 |
T220 |
arg2Of |
COVID-19,with |
R213 |
T222 |
T223 |
arg1Of |
Tocilizumab,"," |
R214 |
T226 |
T223 |
arg2Of |
antibody,"," |
R215 |
T226 |
T224 |
arg1Of |
antibody,a |
R216 |
T226 |
T225 |
arg1Of |
antibody,monoclonal |
R217 |
T226 |
T227 |
arg1Of |
antibody,against |
R218 |
T228 |
T227 |
arg2Of |
IL6,against |